These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 24887560)

  • 21. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
    Tian H; Liu J; Chen J; Gatza ML; Blobe GC
    Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling.
    Khan S; Shukla S; Sinha S; Lakra AD; Bora HK; Meeran SM
    Int J Biochem Cell Biol; 2015 Jan; 58():1-16. PubMed ID: 25448414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer.
    Wu YY; Peck K; Chang YL; Pan SH; Cheng YF; Lin JC; Yang RB; Hong TM; Yang PC
    Oncogene; 2011 Aug; 30(34):3682-93. PubMed ID: 21441952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors.
    Zhao L; Liu S; Che X; Hou K; Ma Y; Li C; Wen T; Fan Y; Hu X; Liu Y; Qu X
    Int J Mol Med; 2015 Sep; 36(3):645-52. PubMed ID: 26133118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo.
    Ge R; Rajeev V; Ray P; Lattime E; Rittling S; Medicherla S; Protter A; Murphy A; Chakravarty J; Dugar S; Schreiner G; Barnard N; Reiss M
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4315-30. PubMed ID: 16857807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leptin promotes metastasis by inducing an epithelial-mesenchymal transition in A549 lung cancer cells.
    Feng H; Liu Q; Zhang N; Zheng L; Sang M; Feng J; Zhang J; Wu X; Shan B
    Oncol Res; 2013; 21(3):165-71. PubMed ID: 24512731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
    Sengupta S; Jana S; Bhattacharyya A
    Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats.
    Laping NJ; Everitt JI; Frazier KS; Burgert M; Portis MJ; Cadacio C; Gold LI; Walker CL
    Clin Cancer Res; 2007 May; 13(10):3087-99. PubMed ID: 17505012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.
    Melisi D; Ishiyama S; Sclabas GM; Fleming JB; Xia Q; Tortora G; Abbruzzese JL; Chiao PJ
    Mol Cancer Ther; 2008 Apr; 7(4):829-40. PubMed ID: 18413796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.
    Muraoka RS; Dumont N; Ritter CA; Dugger TC; Brantley DM; Chen J; Easterly E; Roebuck LR; Ryan S; Gotwals PJ; Koteliansky V; Arteaga CL
    J Clin Invest; 2002 Jun; 109(12):1551-9. PubMed ID: 12070302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells.
    Bartscht T; Lehnert H; Gieseler F; Ungefroren H
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):221-30. PubMed ID: 22699812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis.
    Son JY; Park SY; Kim SJ; Lee SJ; Park SA; Kim MJ; Kim SW; Kim DK; Nam JS; Sheen YY
    Mol Cancer Ther; 2014 Jul; 13(7):1704-16. PubMed ID: 24817629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
    Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Small Dibromotyrosine Derivative Purified From Pseudoceratina Sp. Suppresses TGF-β Responsiveness by Inhibiting TGF-β Type I Receptor Serine/Threonine Kinase Activity.
    Chen CL; Kao YC; Yang PH; Sung PJ; Wen ZH; Chen JJ; Huang YB; Chen PY
    J Cell Biochem; 2016 Dec; 117(12):2800-2814. PubMed ID: 27153151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition.
    Zhou YC; Liu JY; Li J; Zhang J; Xu YQ; Zhang HW; Qiu LB; Ding GR; Su XM; Mei-Shi ; Guo GZ
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1530-7. PubMed ID: 22115555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.